- Home
- GERN vs DNUT Comparison
GERN vs DNUT Comparison
Compare GERN & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- DNUT
- Stock Information
- Founded
- GERN 1990
- DNUT 1937
- Country
- GERN United States
- DNUT United States
- Employees
- GERN N/A
- DNUT N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- DNUT Food Chains
- Sector
- GERN Health Care
- DNUT Consumer Staples
- Exchange
- GERN Nasdaq
- DNUT Nasdaq
- Market Cap
- GERN 840.7M
- DNUT 739.0M
- IPO Year
- GERN 1996
- DNUT 2021
- Fundamental
- Price
- GERN $1.18
- DNUT $2.73
- Analyst Decision
- GERN Buy
- DNUT Buy
- Analyst Count
- GERN 9
- DNUT 8
- Target Price
- GERN $5.13
- DNUT $10.58
- AVG Volume (30 Days)
- GERN 11.5M
- DNUT 6.0M
- Earning Date
- GERN 05-07-2025
- DNUT 05-08-2025
- Dividend Yield
- GERN N/A
- DNUT 5.13%
- EPS Growth
- GERN N/A
- DNUT N/A
- EPS
- GERN N/A
- DNUT N/A
- Revenue
- GERN $116,293,000.00
- DNUT $1,597,883,000.00
- Revenue This Year
- GERN $194.54
- DNUT N/A
- Revenue Next Year
- GERN $56.51
- DNUT $9.87
- P/E Ratio
- GERN N/A
- DNUT N/A
- Revenue Growth
- GERN 22264.04
- DNUT N/A
- 52 Week Low
- GERN $1.17
- DNUT $3.03
- 52 Week High
- GERN $5.34
- DNUT $13.25
- Technical
- Relative Strength Index (RSI)
- GERN 32.46
- DNUT 20.89
- Support Level
- GERN $1.34
- DNUT $4.17
- Resistance Level
- GERN $1.44
- DNUT $4.44
- Average True Range (ATR)
- GERN 0.10
- DNUT 0.27
- MACD
- GERN 0.00
- DNUT -0.06
- Stochastic Oscillator
- GERN 3.23
- DNUT 7.50
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.